Converting milligrams to millilitres takes one division: volume in mL = dose in mg divided by the concentration in mg/mL. So 2.5 mg is 0.5 mL from a vial labelled 5 mg/mL, 0.25 mL from 10 mg/mL and 0.125 mL from 20 mg/mL.
There is no single answer without the concentration, and that is the part most searches leave out. Below is the formula in both directions, every labelled tirzepatide and semaglutide dose worked out at the concentrations actually in circulation, and why a figure like 2.5 mL is usually a vial size rather than a dose.
- mL = mg divided by mg/mL. The reverse is mg = mL multiplied by mg/mL.
- The same 2.5 mg dose is 0.5 mL, 0.25 mL or 0.125 mL depending only on whether the vial is 5, 10 or 20 mg/mL.
- Every branded tirzepatide strength from 2.5 mg to 15 mg is delivered in the same 0.5 mL, so volume alone never identifies a dose.
- On a U-100 syringe 1 unit is 0.01 mL; on a U-40 syringe it is 0.025 mL, which is where ten-fold errors start.
- Published poison-centre case series record ten-fold compounded semaglutide errors traced to dosing in millilitres and units rather than milligrams.
The formula, in both directions
A millilitre is a volume. A milligram is a mass of drug. The only thing that connects them is the concentration printed on the vial, written as mg per mL.
- mg to mL: volume in mL = dose in mg divided by the concentration in mg/mL
- mL to mg: dose in mg = volume in mL multiplied by the concentration in mg/mL
So 2.5 mg from a vial labelled 5 mg/mL is 2.5 divided by 5, which is 0.5 mL. The same 2.5 mg from a 20 mg/mL vial is 0.125 mL, a quarter of that volume for exactly the same amount of drug. Change the vial and the number changes, which is why no article, chart or calculator can answer "2.5 mg to mL" without being told the concentration first.
Every tirzepatide dose, at the concentrations in circulation
Branded tirzepatide is supplied at a different concentration for every strength, so a compounded vial is where the arithmetic actually comes up. These are the concentrations that turn up on compounded labels. Read down the column for your vial.
| Dose | 5 mg/mL | 10 mg/mL | 15 mg/mL | 20 mg/mL | 30 mg/mL |
|---|---|---|---|---|---|
| 2.5 mg | 0.5 mL | 0.25 mL | 0.167 mL | 0.125 mL | 0.083 mL |
| 5 mg | 1 mL | 0.5 mL | 0.333 mL | 0.25 mL | 0.167 mL |
| 7.5 mg | 1.5 mL | 0.75 mL | 0.5 mL | 0.375 mL | 0.25 mL |
| 10 mg | 2 mL | 1 mL | 0.667 mL | 0.5 mL | 0.333 mL |
| 12.5 mg | 2.5 mL | 1.25 mL | 0.833 mL | 0.625 mL | 0.417 mL |
| 15 mg | 3 mL | 1.5 mL | 1 mL | 0.75 mL | 0.5 mL |
Two things fall out of that table. The first is the spread: 15 mg is anywhere between 0.5 mL and 3 mL depending on nothing but the concentration. The second is that several of those volumes do not fit in a 1 mL syringe at all. A figure like 2.5 mL or 3 mL is a sign that the concentration being used in the sum is not the concentration in the vial.
Semaglutide, same arithmetic, smaller numbers
Semaglutide doses are an order of magnitude smaller, so the volumes land in a range where a tenth of a millilitre matters.
| Dose | 1 mg/mL | 2 mg/mL | 2.5 mg/mL | 5 mg/mL |
|---|---|---|---|---|
| 0.25 mg | 0.25 mL | 0.125 mL | 0.1 mL | 0.05 mL |
| 0.5 mg | 0.5 mL | 0.25 mL | 0.2 mL | 0.1 mL |
| 1 mg | 1 mL | 0.5 mL | 0.4 mL | 0.2 mL |
| 1.7 mg | 1.7 mL | 0.85 mL | 0.68 mL | 0.34 mL |
| 2.4 mg | 2.4 mL | 1.2 mL | 0.96 mL | 0.48 mL |
At 5 mg/mL, the difference between a 0.25 mg starting dose and a 0.5 mg dose is five hundredths of a millilitre. That is below the resolution most people can read reliably off a syringe barrel, and it is the reason doses in this range are usually described in units rather than millilitres.
"2.5 mL to mg" is almost always a misread
The reverse search is common enough to be worth answering directly, because the answer is usually that the number is not a dose.
Run it through the formula and 2.5 mL is 12.5 mg from a 5 mg/mL vial, 25 mg from a 10 mg/mL vial and 50 mg from a 20 mg/mL vial. Those are large amounts of drug. Meanwhile every branded tirzepatide pen and vial delivers its dose in 0.5 mL, and branded semaglutide pens deliver 0.5 mL or 0.75 mL.
So a 2.5 mL figure on a label is far more likely to be the total volume of liquid in the vial than the volume of a single dose. A 2.5 mL vial at 20 mg/mL holds 50 mg of drug, which at a 5 mg dose is ten doses of 0.25 mL. Reading the vial total as a dose is a ten-fold error, and it is exactly the shape of error that has reached poison control centres.
What the branded products read, and why mL tells you nothing there
On manufactured pens the volume is fixed and the concentration moves instead, so the millilitre figure carries no information about the dose.
| Product | Dose in the device | Volume | Concentration |
|---|---|---|---|
| Mounjaro or Zepbound, every strength | 2.5 mg to 15 mg | 0.5 mL | 5 to 30 mg/mL |
| Wegovy single-dose pen, 0.25 mg | 0.25 mg | 0.5 mL | 0.5 mg/mL |
| Wegovy single-dose pen, 2.4 mg | 2.4 mg | 0.75 mL | 3.2 mg/mL |
| Ozempic pen, 2 mg | Delivers 0.25 or 0.5 mg | Multi-dose | 0.68 mg/mL |
| Ozempic pen, 8 mg | Delivers 2 mg | Multi-dose | 2.68 mg/mL |
Every tirzepatide strength from 2.5 mg to 15 mg is the same 0.5 mL of liquid. A six-fold difference in drug, an identical volume. That is the clearest demonstration that millilitres and milligrams are not interchangeable, and the pen is what removes the arithmetic rather than anything about the molecule.
mL, units and the syringe barrel
Millilitres and units measure the same thing on an insulin syringe. A U-100 syringe is graduated so that 100 units equals 1 mL, which makes 1 unit 0.01 mL. A dose of 0.25 mL is 25 units on that scale, and 0.5 mL is 50 units.
The catch is the U-40 syringe, still sold for veterinary insulin, where 40 units equals 1 mL and 1 unit is 0.025 mL. The same 0.25 mL is 10 units on that barrel. We set out the unit conversion and both syringe scales in full in the piece on converting mg to units, and worked through the single most searched case in how many units 2.5 mg of tirzepatide is.
Why the volume is where errors start
Peer-reviewed poison-centre case series describe ten-fold compounded semaglutide overdoses in which patients were dosing in millilitres and units rather than milligrams, and in which a vial and syringes were handed over with no counselling on how to measure a dose (PMID 37392810, PMID 38470137). The FDA issued a compounding risk alert covering the same pattern in July 2024.
The volume is where these go wrong because it is the only number in the chain that has to be produced by arithmetic rather than read off a label. The dose is prescribed, the concentration is printed, the volume is calculated. A factor-of-ten slip there survives all the way to the syringe. We set out those case series in full, and what each one got wrong, in the mg to units piece.
Three checks that catch most mistakes
- Read the concentration, not the total. A vial labelled "10 mg/2 mL" is a 5 mg/mL vial holding 10 mg. A vial labelled "10 mg" with no volume is not enough information to do the sum.
- Sanity-check the volume against the syringe. If the answer is larger than the syringe holds, the concentration in the sum is wrong.
- Count the decimal places twice. Most published errors are factor-of-ten errors, and a factor of ten is one misplaced decimal point.
None of this replaces the instruction on the prescription. The arithmetic only tells you what a given volume of a given concentration contains. What dose is appropriate, and whether a product is appropriate at all, is a decision for the prescriber who wrote it.
See what a dose is expected to deliver
Turn the published trial percentages into a pound figure from your own starting weight.
Once the volume question is settled, the next one is usually what the dose is expected to do. Our GLP-1 weight loss calculator puts the published trial percentages against a starting weight, which is a more useful reference point than a single population average.
FAQ
How many mL is 2.5 mg?
It depends entirely on the concentration. 2.5 mg is 0.5 mL from a 5 mg/mL vial, 0.25 mL from 10 mg/mL, 0.167 mL from 15 mg/mL and 0.125 mL from 20 mg/mL. The sum is 2.5 divided by the mg/mL figure printed on the vial.
How many mg is 2.5 mL?
Multiply 2.5 by the concentration: 12.5 mg at 5 mg/mL, 25 mg at 10 mg/mL and 50 mg at 20 mg/mL. In practice a 2.5 mL figure on a label is usually the total volume in the vial rather than a single dose, because branded GLP-1 injections deliver 0.5 mL or 0.75 mL.
How many mL is 7.5 mg of tirzepatide?
1.5 mL at 5 mg/mL, 0.75 mL at 10 mg/mL, 0.5 mL at 15 mg/mL, 0.375 mL at 20 mg/mL and 0.25 mL at 30 mg/mL. The branded 7.5 mg pen contains 7.5 mg in 0.5 mL, which is a 15 mg/mL concentration.
Is 1 mL the same as 100 units?
On a U-100 insulin syringe, yes: 100 units is graduated to 1 mL, so one unit is 0.01 mL. On a U-40 syringe, 40 units is 1 mL and one unit is 0.025 mL. Units measure volume on both, not an amount of drug.
Why do pens not list a volume per dose?
Because on manufactured pens the volume is fixed and the concentration changes with the strength. Every tirzepatide strength from 2.5 mg to 15 mg comes in 0.5 mL, so the volume is identical across a six-fold range of drug and tells you nothing about the dose.
Does the conversion change for compounded products?
The arithmetic is the same, but compounded vials come in concentrations that branded products never use, including 15, 20, 30 and 34 mg/mL for tirzepatide. That is why the concentration has to be read off the vial in front of you rather than assumed from a chart.
Sources
- Wiener BG, Gnirke M, Vassallo S, Smith SW, Su MK. Challenges with glucagon-like peptide-1 (GLP-1) agonist initiation: a case series of semaglutide overdose administration errors. Clin Toxicol (Phila). 2024;62(2):131-133. PMID: 38470137
- Lambson JE, Flegal SC, Johnson AR. Administration errors of compounded semaglutide reported to a poison control center: case series. J Am Pharm Assoc (2003). 2023;63(5):1643-1645. PMID: 37392810
- US Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. Compounding risk alert, July 2024.
- Wegovy (semaglutide) injection, US prescribing information, Novo Nordisk. Single-dose pen strengths 0.25, 0.5, 1 and 1.7 mg, 2.4 mg and 7.2 mg; injection volumes 0.5 mL and 0.75 mL.
- Ozempic (semaglutide) injection, US prescribing information, Novo Nordisk. Pen concentrations 0.68, 1.34 and 2.68 mg/mL.
- Mounjaro and Zepbound (tirzepatide) injection, US prescribing information, Eli Lilly. Each single-dose pen or vial contains 2.5 to 15 mg per 0.5 mL.
This article is for information only and is not medical advice. Dosing, suitability and any change to treatment are decisions for your prescriber.